等待开盘 11-17 09:30:00 美东时间
-0.469
-1.42%
数据显示,FSGS前十大重仓股合计占基金资产的11.8031%。 其中,第一大重仓股为神经分泌生物科学,持仓占比1.2498%;第二大重仓股为CLEAR Se...
11-14 07:08
Akebia Therapeutics reported Q3 2026 financial results, highlighting a 140% increase in Vafseo® (vadadustat) patients compared to Q3 2025, reaching approximately 11,500. Vafseo net product revenues were $14.8 million, though impacted by inventory adjustments. Positive clinical data from the VOICE and VOCAL trials demonstrated improved safety and non-inferiority to ESA in maintaining hemoglobin. Akebia also initiated a Phase 2 trial for ebribafusp...
11-05 12:10
The latest announcement is out from Dimerix Limited ( ($AU:DXB) ). Dimerix has ...
10-23 06:59
Travere Therapeutics (TVTX) has appointed Bradley Campbell as chief executive officer, effective December 1, 2026, the compnay said on Monday. The announcement came after Eric Dube said he will step d...
09-22 04:24
2026年8月20日,莫德纳与默沙东合作的mRNA个性化肿瘤疫苗III期临床取得阳性结果。消息一出,云顶新耀盘中涨幅一度触及89%,累计四个交易日涨幅达到54...
08-26 09:02
Patients in the study who initiated and remained on FILSPARI maintained durable and deepened proteinuria reductions, resulting in further achievement of clinically meaningful low proteinuria thresholds over timePatients
06-04 22:10
Travere Therapeutics (TVTX) on Wednesday announced the pricing of its underwritten offering of $475M aggregate principal amount of 0.50% convertible senior notes due 2032. The sale of the notes is exp...
05-07 13:05